These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1314 related items for PubMed ID: 24095761

  • 1. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J, Szafrański K, Vullo D, Supuran CT.
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z, Sławiński J, Vullo D, Supuran CT.
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J, Brzozowski Z, Żołnowska B, Szafrański K, Pogorzelska A, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Sep 12; 84():59-67. PubMed ID: 25016228
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B, Sławiński J, Pogorzelska A, Chojnacki J, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jan 12; 71():135-47. PubMed ID: 24291567
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Sławiński J, Pogorzelska A, Żołnowska B, Brożewicz K, Vullo D, Supuran CT.
    Eur J Med Chem; 2014 Jul 23; 82():47-55. PubMed ID: 24871996
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z, Sławiński J, Gdaniec M, Innocenti A, Supuran CT.
    Eur J Med Chem; 2011 Sep 23; 46(9):4403-10. PubMed ID: 21820216
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: synthesis and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with 4-substituted 3-pyridinesulfonamides.
    Brzozowski Z, Sławiński J, Saczewski F, Innocenti A, Supuran CT.
    Eur J Med Chem; 2010 Jun 23; 45(6):2396-404. PubMed ID: 20202722
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Regioselective synthesis of novel 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z, Sławiński J, Innocenti A, Supuran CT.
    Eur J Med Chem; 2010 Sep 23; 45(9):3656-61. PubMed ID: 20554082
    [Abstract] [Full Text] [Related]

  • 9. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam, Celik G, Khloya P, Vullo D, Supuran CT, Sharma PK.
    Bioorg Med Chem; 2014 Mar 15; 22(6):1873-82. PubMed ID: 24560737
    [Abstract] [Full Text] [Related]

  • 10. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B, Sławiński J, Szafrański K, Angeli A, Supuran CT, Kawiak A, Wieczór M, Zielińska J, Bączek T, Bartoszewska S.
    Eur J Med Chem; 2018 Jan 01; 143():1931-1941. PubMed ID: 29146134
    [Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F, Innocenti A, Sławiński J, Kornicka A, Brzozowski Z, Pomarnacka E, Scozzafava A, Temperini C, Supuran CT.
    Bioorg Med Chem; 2008 Apr 01; 16(7):3933-40. PubMed ID: 18242998
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK, Vullo D, Verma SM, Tanç M, Carta F, Supuran CT.
    Bioorg Med Chem; 2013 Oct 01; 21(19):5973-82. PubMed ID: 23965175
    [Abstract] [Full Text] [Related]

  • 13. Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties.
    Ghorab MM, Alsaid MS, Ceruso M, Nissan YM, Supuran CT.
    Bioorg Med Chem; 2014 Jul 15; 22(14):3684-95. PubMed ID: 24878360
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L, Fasolis G, Vullo D, Chohan ZH, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3096-101. PubMed ID: 15908204
    [Abstract] [Full Text] [Related]

  • 15. Synthesis, carbonic anhydrase inhibition and cytotoxic activity of novel chromone-based sulfonamide derivatives.
    Awadallah FM, El-Waei TA, Hanna MM, Abbas SE, Ceruso M, Oz BE, Guler OO, Supuran CT.
    Eur J Med Chem; 2015 Jun 15; 96():425-35. PubMed ID: 25912674
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
    Congiu C, Onnis V, Deplano A, Balboni G, Dedeoglu N, Supuran CT.
    Bioorg Med Chem Lett; 2015 Sep 15; 25(18):3850-3. PubMed ID: 26233435
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V, Puccetti L, Fasolis G, Winum JY, Montero JL, Scozzafava A, Vullo D, Innocenti A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3102-8. PubMed ID: 15905091
    [Abstract] [Full Text] [Related]

  • 18. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents.
    Hao S, Cheng X, Wang X, An R, Xu H, Guo M, Li C, Wang Y, Hou Z, Guo C.
    Bioorg Chem; 2020 Nov 15; 104():104237. PubMed ID: 32911194
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and characterization of metal complexes of heterocyclic sulfonamide as carbonic anhydrase inhibitors.
    Büyükkidan N, Bülbül M, Kasimoğullari R, Büyükkidan B.
    J Enzyme Inhib Med Chem; 2013 Apr 15; 28(2):311-5. PubMed ID: 22957724
    [Abstract] [Full Text] [Related]

  • 20. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
    Soliman AM, Ghorab MM, Bua S, Supuran CT.
    Eur J Med Chem; 2020 Aug 15; 200():112449. PubMed ID: 32485534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 66.